RS Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$34.9M Buy
1,505,004
+98,038
+7% +$2.44M 0.36% 97
2016
Q1
$38.5M Sell
1,406,966
-37,660
-3% -$788K 0.38% 96
2015
Q4
$41.1M Sell
1,444,626
-104,674
-7% -$2.81M 0.37% 97
2015
Q3
$27.1M Buy
1,549,300
+356,899
+30% +$6.98M 0.24% 151
2015
Q2
$21.5M Buy
1,192,401
+358,360
+43% +$4.9M 0.18% 183
2015
Q1
$10.4M Buy
834,041
+99,900
+14% +$1.24M 0.09% 240
2014
Q4
$8.63M Buy
734,141
+134,741
+22% +$1.57M 0.08% 252
2014
Q3
$7.87M Buy
+599,400
New +$7.78M 0.07% 257

Other funds holding LOXO

RS Investment Management's LOXO Position: Q2 2016 in Review

RS Investment Management increased its Loxo Oncology, Inc (LOXO) stake by 7% in Q2 2016, buying an estimated $2.44M and bringing the position to 1,505,004 shares worth $34.9M. The position accounts for 0.36% of the portfolio, ranked #97.

RS Investment Management first reported a position in LOXO in Q3 2014 and has held it in 8 quarters since. The position peaked at $41.1M in Q4 2015. 73 funds tracked by Wall St. Rank hold LOXO as of Q2 2016.

  • RS Investment Management held 1,505,004 shares of Loxo Oncology, Inc worth $34.9M as of Q2 2016.
  • RS Investment Management bought 98,038 Loxo Oncology, Inc shares in Q2 2016, an estimated $2.44M.
  • Loxo Oncology, Inc made up 0.36% of RS Investment Management's portfolio in Q2 2016, its #97 holding.
  • RS Investment Management first reported a position in Loxo Oncology, Inc in Q3 2014 and has held it in 8 quarters since.
  • RS Investment Management's Loxo Oncology, Inc position peaked at $41.1M in Q4 2015.
  • 73 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.